Lipoprotein(a) and coronary heart disease risk.

This publication has 47 references indexed in Scilit:

• The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle‐aged black and white women from the United States
  Journal of Internal Medicine, 1998
• Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A‐I is protective for the incidence of primary acute myocardial infarction in middle‐aged males. An incident case–control study from Sweden
  Journal of Internal Medicine, 1998
• Apolipoprotein(a) Enhances Platelet Responses to the Thrombin Receptor–Activating Peptide SFLLRN
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Apolipoprotein(a) Binds to Low-Density Lipoprotein at Two Distant Sites in Lipoprotein(a)
  Biochemistry, 1998
• Lipoprotein(a): structural implications for pathophysiology
  International Journal of Clinical and Laboratory Research, 1997
• Site-specific Mutagenesis Demonstrates That Cysteine 4326 of Apolipoprotein B Is Required for Covalent Linkage with Apolipoprotein(a) in Vivo
  Published by Elsevier ,1995
• No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques
  Atherosclerosis, 1995
• Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratio
  The American Journal of Cardiology, 1993
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
  Nature, 1987